Published in Nephrol Dial Transplant on February 01, 2003
Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol (2010) 1.51
New pharmacological treatments for improving renal outcomes in diabetes. Nat Rev Nephrol (2010) 1.29
Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment. Semin Nephrol (2007) 1.20
Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages. Am J Pathol (2010) 0.99
Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy. ScientificWorldJournal (2013) 0.92
The genetics of diabetic nephropathy. Genes (Basel) (2013) 0.90
Resveratrol Prevention of Diabetic Nephropathy Is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-κB Pathway. Int J Endocrinol (2014) 0.88
Microinflammation in the pathogenesis of diabetic nephropathy. J Diabetes Investig (2013) 0.86
Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats. Pediatr Nephrol (2008) 0.83
Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina. Jpn J Ophthalmol (2007) 0.83
Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus. Ren Fail (2009) 0.83
Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat. BMC Complement Altern Med (2014) 0.81
Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway. Int J Endocrinol (2013) 0.79
Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients. Clin Exp Nephrol (2010) 0.78
The effects of anti-inflammatory and anti-angiogenic DNA vaccination on diabetic nephropathy in rats. Hum Gene Ther (2012) 0.78
Systemic and renal lipids in kidney disease development and progression. Am J Physiol Renal Physiol (2015) 0.77
The effect of statin on epithelial-mesenchymal transition in peritoneal mesothelial cells. PLoS One (2014) 0.76
About the pleiotropic effects of statins in human. Nephrol Dial Transplant (2003) 0.75
Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor. Sci Rep (2016) 0.75
Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy. Int J Clin Exp Pathol (2015) 0.75
Historical chronology of basic and clinical research in diabetic nephropathy and contributions of Japanese scientists. Clin Exp Nephrol (2009) 0.75
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol (2009) 6.39
Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol (2005) 5.52
The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77
Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther (2008) 3.44
Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis (2007) 2.74
Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest (2007) 2.73
Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood) (2008) 2.70
miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J Biol Chem (2009) 2.68
Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol (2009) 2.66
Relationship between metabolic syndrome and proteinuria in the Japanese population. Intern Med (2006) 2.58
Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol (2007) 2.58
Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum (2004) 2.52
Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens (2008) 2.42
Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A (2005) 2.31
Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol (2007) 2.20
Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol (2011) 2.12
Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice. Circulation (2005) 2.09
Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy. Nephrol Dial Transplant (2009) 2.08
Variations in the FTO gene are associated with severe obesity in the Japanese. J Hum Genet (2008) 2.03
CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum (2002) 2.01
Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol (2002) 2.01
TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med (2008) 1.99
Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol (2012) 1.95
Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res (2006) 1.91
Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes (2003) 1.91
Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med (2006) 1.88
MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol (2011) 1.86
Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci U S A (2007) 1.83
Small interfering RNA-mediated silencing induces target-dependent assembly of GW/P bodies. Mol Biol Cell (2007) 1.83
Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum (2007) 1.80
NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol (2005) 1.78
The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab (2005) 1.72
Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res (2008) 1.70
Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond) (2013) 1.69
Risk factors associated with relapse in Japanese patients with microscopic polyangiitis. J Rheumatol (2011) 1.69
The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther (2006) 1.67
Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol (2009) 1.64
The role of GW/P-bodies in RNA processing and silencing. J Cell Sci (2007) 1.63
Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting. Arch Intern Med (2004) 1.63
Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol (2010) 1.58
Smooth muscle Notch1 mediates neointimal formation after vascular injury. Circulation (2009) 1.58
Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. J Immunol (2003) 1.54
Identification of GW182 and its novel isoform TNGW1 as translational repressors in Ago2-mediated silencing. J Cell Sci (2008) 1.53
Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol (2011) 1.52
Abrupt enlargement of adrenal incidentaloma: a case of isolated adrenal metastasis. Endocr J (2005) 1.51
Pristane-induced autoimmunity in germ-free mice. Clin Immunol (2005) 1.51
A novel type I IFN-producing cell subset in murine lupus. J Immunol (2008) 1.50
CDH13 Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass. J Atheroscler Thromb (2015) 1.50
Long-term outcome and prognostic factors of elderly patients with acute promyelocytic leukemia. Cancer Sci (2012) 1.48
Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells. PLoS One (2011) 1.47
Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am J Pathol (2009) 1.47
Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane). Am J Pathol (2006) 1.47
Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J (2005) 1.45
Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J Immunol (2003) 1.44
The MUSCAT study: a Multicenter PROBE Study Comparing the Effects of Angiotensin II Type-1 Receptor Blockers on Self-Monitored Home Blood Pressure in Patients with Morning Hypertension: study design and background characteristics. Hypertens Res (2008) 1.44
[A preliminary report of national research on podocytic infolding glomerulopathy]. Nihon Jinzo Gakkai Shi (2007) 1.44
A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol (2009) 1.44
Effects of dual blockade of the renin-angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT-Hypertension). Hypertens Res (2013) 1.42
An extra-adrenal abdominal pheochromocytoma causing ectopic ACTH syndrome. Am J Hypertens (2005) 1.42
Intoxication with over-the-counter antitussive medication containing dihydrocodeine and chlorpheniramine causes generalized convulsion and mixed acidosis. Intern Med (2008) 1.41
Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol (2010) 1.39
Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res (2008) 1.39
Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology (2009) 1.37
Autoimmune targeting of key components of RNA interference. Arthritis Res Ther (2006) 1.32
Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J Clin Invest (2006) 1.31
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. Am J Physiol Renal Physiol (2006) 1.31
Pirfenidone is renoprotective in diabetic kidney disease. J Am Soc Nephrol (2009) 1.29
Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum (2006) 1.28
ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol (2012) 1.27
Association of anti-nucleoprotein autoantibodies with upregulation of Type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus. Clin Immunol (2005) 1.26
Role of Nox2 in diabetic kidney disease. Am J Physiol Renal Physiol (2013) 1.24
Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis. Arthritis Res Ther (2010) 1.24
A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther (2003) 1.23
Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol (2006) 1.23
TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun (2007) 1.23
Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes (2004) 1.23
Analysis of novel disease-related genes in bronchial asthma. Cytokine (2002) 1.22
Involvement of the protein kinase CK2 in the regulation of mammalian circadian rhythms. Sci Signal (2009) 1.21
Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody. J Immunol Methods (2006) 1.20
Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol (2013) 1.20
MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells. Neuro Oncol (2013) 1.20
Clinical features of non-diabetic renal diseases in patients with type 2 diabetes. Diabetes Res Clin Pract (2005) 1.20